Related Experiment Video
Updated: May 8, 2026
Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat
Published on: June 4, 2012
Marrow mesenchymal stromal cells reduce methicillin-resistant Staphylococcus aureus infection in rat models
Yuan Yuan1, Songyi Lin1, Na Guo1
1Department of Food Quality and Safety, College of Agriculture, Jilin University, Changchun, China.
Background Aims:
Staphylococci account for a large proportion of hospital-acquired infections, especially among patients with indwelling devices. These infections are often caused by biofilm-producing strains, which are difficult to eradicate and may eventually cause bacteremia and metastatic infections. Recent evidence suggests that mesenchymal stem cells can enhance bacterial clearance in vivo.
Methods:
In this study, a rat model with carboxymethyl cellulose pouch infection was used to analyze the efficacy of bone marrow-derived mesenchymal stromal cells (BMSCs) against the methicillin-resistant Staphylococcus aureus.
Results:
The results showed that the administration of BMSCs effectively reduced the number of bacterial colonies and the expression of many cytokines and chemokines (such as interleukin [IL]-6, IL-1β, IL-10 and CCL5). Unlike the fibroblast control groups, the pouch tissues from the BMSC-treated rats showed the formation of granulations, suggesting that the healing of the wound was in progress.
Conclusions:
The results indicate that the treatment of BMSCs can reduce methicillin-resistant S aureus infection in vivo, thereby reducing the inflammatory response.
Insights
Bone marrow-derived mesenchymal stromal cells (BMSCs) effectively reduced methicillin-resistant Staphylococcus aureus infections in a rat model. This treatment also decreased inflammatory cytokines and promoted wound healing, offering a potential new therapeutic strategy.
Area of Science:
- Stem cell therapy
- Infectious disease research
- Wound healing
Background:
- Staphylococci are a major cause of hospital-acquired infections, particularly in patients with indwelling devices.
- Biofilm-producing strains of Staphylococcus are challenging to eradicate and can lead to severe complications like bacteremia.
- Mesenchymal stem cells show promise in enhancing bacterial clearance in vivo.
Purpose of the Study:
- To evaluate the efficacy of bone marrow-derived mesenchymal stromal cells (BMSCs) against methicillin-resistant Staphylococcus aureus (MRSA) infection.
- To investigate the impact of BMSCs on bacterial load and inflammatory markers.
- To assess the effect of BMSCs on wound healing in an infected tissue model.
Main Methods:
- A rat model utilizing a carboxymethyl cellulose pouch infection was established.
- The efficacy of BMSCs was analyzed in reducing bacterial colonies and inflammatory cytokine expression.
- Tissue healing was assessed by observing granulation formation in BMSC-treated groups compared to controls.
Main Results:
- BMSC administration significantly reduced the number of bacterial colonies.
- Treatment with BMSCs led to decreased expression of key cytokines and chemokines (e.g., IL-6, IL-1β, IL-10, CCL5).
- BMSC-treated rats exhibited granulation tissue formation, indicating wound healing progression, unlike fibroblast control groups.
Conclusions:
- BMSCs demonstrate efficacy in reducing in vivo methicillin-resistant Staphylococcus aureus infection.
- BMSC treatment effectively mitigates the associated inflammatory response.
- Mesenchymal stem cell therapy presents a viable approach for managing MRSA infections and promoting tissue repair.
Related Concept Videos
01:25Clinical Significance of Antibiotic Resistance
01:19Mesenchymal Stem Cells